Public Law 115-271, SUPPORT for Patients and Communities Act
Duration: April 4, 2016
to
December 31, 2018
General Issues: Alcohol & Drug Abuse , Health Issues
Spending: about $310,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: House of Representatives, U.S. Senate, Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA)
Affiliated organizations: American Society of Addiction Medicine
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2018
CAPITOL DECISIONS, INC. terminated an engagement in which they represented Coalition to Stop Opioid Overdose (Informal Coalition) on Jan. 22, 2019.
Original Filing: 301013121.xml
Lobbying Issues
Public Law 115-271, SUPPORT for Patients and Communities Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
3rd Quarter, 2018
In Q3, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $10,000. The report was filed on Oct. 19, 2018.
Original Filing: 300992232.xml
Lobbying Issues
H.R.5102/S.2524, Substance Use Disorder Loan Repayment Act
H.R.6, SUPPORT for Patients and Communities Act
S.2680, Opioid Crisis Response Act
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
2nd Quarter, 2018
In Q2, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $10,000. The report was filed on July 19, 2018.
Original Filing: 300971375.xml
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, generally
H.R.3382, Youth Opioid Use Treatment Act
H.R.5102/S.2524, Substance Use Disorder Loan Repayment Act
S.2711, Enhancing Access to Opioid Treatment Act
S.2406, ACE Research Act
H.R. 6, SUPPORT for Patients and Communities Act
S.2680, Opioid Crisis Response Act
S.3120, HEAL Act of 2018
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $10,000. The report was filed on April 19, 2018.
Original Filing: 300949424.xml
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, generally
H.R.3382, Youth Opioid Use Treatment Act
H.R.5102/S.2524, Substance Use Disorder Loan Repayment Act
Draft bill, Enhancing Access to Opioid Treatment Act
S.2406, ACE Research Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300932411.xml
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
H.R.3382, Youth Opioid Use Treatment Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $20,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911332.xml
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
H.R.3382, Youth Opioid Use Treatment Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $30,000. The report was filed on July 19, 2017.
Original Filing: 300890085.xml
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, generally
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $20,000. The report was filed on April 19, 2017.
Original Filing: 300871579.xml
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, generally
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2018, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 114-198, Comprehensive Addiction and Recovery Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
H.R.1628, American Health Care Act of 2017, Addiction treatment coverage
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $50,000. The report was filed on Jan. 20, 2017.
Original Filing: 300853099.xml
Lobbying Issues
S.1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, Access to medication assisted treatment
H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act, Access to medication assisted treatment
H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, Treatment for pregnant and postpartum women
H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016, Naloxone coprescribing
H.R.1725/S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, Prescription drug monitoring
H.R.4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act", Prescribing guidelines
H.R.953/S.524, Comprehensive Addiction and Recovery Act of 2015, generally
H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016
Public Law 114-255, 21st Century Cures Act, generally
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, generally
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, Access to medication assisted treatment
H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act, Access to medication assisted treatment
H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, Treatment for pregnant and postpartum women
H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016, Naloxone coprescribing
H.R.1725/S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, Prescription drug monitoring
H.R.4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act", Prescribing guidelines
H.R.953/S.524, Comprehensive Addiction and Recovery Act of 2015, generally
H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016, generally
Public Law 114-255, 21st Century Cures Act, generally
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $50,000. The report was filed on Oct. 18, 2016.
Original Filing: 300830170.xml
Lobbying Issues
S.1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, Access to medication assisted treatment
H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act, Access to medication assisted treatment
H.R.3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, Treatment for pregnant and postpartum women
H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016, Naloxone coprescribing
H.R.1725/S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, Prescription drug monitoring
H.R.4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act", Prescribing guidelines
H.R.953/S.524, Comprehensive Addiction and Recovery Act of 2015, generally
H.R.5046, Comprehensive Opioid Abuse Reduction Act of 2016
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
2nd Quarter, 2016
In Q2, CAPITOL DECISIONS, INC. lobbied for Coalition to Stop Opioid Overdose (Informal Coalition) , earning $60,000. The report was filed on July 19, 2016.
Original Filing: 300812813.xml
Lobbying Issues
S.1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, Access to medication assisted treatment
H.R.4981, Opioid Use Disorder Treatment Expansion and Modernization Act, Access to medication assisted treatment
H.R.3691, Opioid Use Disorder Treatment Expansion and Modernization Act, Treatment for pregnant and postpartum women
H.R.3680, Co-Prescribing to Reduce Overdoses Act of 2016, Naloxone coprescribing
H.R.1725/S.480, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, Prescription drug monitoring
H.R.4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act", Prescribing guidelines
H.R.953/S.524, Comprehensive Addiction and Recovery Act of 2015, generally
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
2nd Quarter, 2016
Capitol Decisions, Inc. filed a lobbying registration on May 16, 2016 to represent Coalition to Stop Opioid Overdose (Informal Coalition), effective April 4, 2016.
Original Filing: 300805316.xml
Issue(s) they said they’d lobby about: Opioid misuse and overdose epidemic related issues and initiatives .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...